SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-015061
Filing Date
2022-05-25
Accepted
2022-05-25 17:12:02
Documents
16
Period of Report
2022-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50696
2 ex5-1.htm EX-5.1 18885
3 ex5-1_001.jpg GRAPHIC 5512
4 ex5-1_002.jpg GRAPHIC 8046
5 ex10-1.htm EX-10.1 258227
  Complete submission text file 0001493152-22-015061.txt   584678

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20220525.xsd EX-101.SCH 2956
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20220525_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20220525_pre.xml EX-101.PRE 22357
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 22964064
SIC: 2834 Pharmaceutical Preparations